Misrai Vincent, Rijo Enrique, Cottenceau Jean-Baptiste, Zorn Kevin C, Enikeev Dmitry, Elterman Dean, Bhojani Naeem, De La Taille Alexandre, Herrmann Thomas R W, Robert Gregoire, Pradere Benjamin
From the Department of Urology, Clinique Pasteur, Toulouse, France.
Department of Urology, Hospital Quiron Barcelona, Barcelona, Spain.
Ann Surg Open. 2021 Sep 7;2(3):e094. doi: 10.1097/AS9.0000000000000094. eCollection 2021 Sep.
To propose a standardized methodology for estimating the embodied carbon footprint (CF) of disposable minimally-invasive surgical devices (MISDs) and their application in new benign prostatic hyperplasia (BPH) MISDs.
The estimation of the CO emissions of disposable surgical devices is central to empowering the healthcare supply chain.
The proposed methodology relied on a partial product lifecycle assessment and was restricted to a specific part of scope 3, which comprised the manufacturing of surgical device- and non-device-associated products (NDAPs), including packaging and user manual. The process-sum inventory method was used, which involves collecting data on all the component processes underpinning disposable MISDs. The seven latest disposable MISDs used worldwide for transurethral prostatic surgery were dismantled, and each piece was categorized, sorted into the appropriate raw material group, and weighed. The CF was estimated according to the following formula: activity data (weight of raw material) × emission factors of the corresponding raw material (kg CO/kg).
The total weights of disposable packaging and user manuals ranged from 0.062 to 1.013 kg. Plastic was the most common and least emissive raw material (2.38 kg CO/kg) identified. The estimated embodied CF of MISDs ranged from 0.07 to 3.3 kg CO, of which 9% to 86% was attributed to NDAPs.
This study described a simple and independent calculation method for estimating the embodied CF of MISDs. Using this method, our results showed a wide discrepancy in the estimated CO emissions of the most recent disposable MISDs for transurethral BPH surgery. Thus, the lack of CF information should be of major concern in the development of future MISDs.
提出一种标准化方法,用于估算一次性微创外科手术器械(MISD)的隐含碳足迹(CF)及其在新型良性前列腺增生(BPH)MISD中的应用。
一次性手术器械的碳排放估算对于优化医疗供应链至关重要。
所提出的方法依赖于部分产品生命周期评估,并局限于范围3的特定部分,该部分包括手术器械及非器械相关产品(NDAP)的制造,包括包装和用户手册。采用过程总和清单法,即收集支撑一次性MISD的所有组成过程的数据。拆解了全球范围内用于经尿道前列腺手术的七种最新一次性MISD,对每个部件进行分类,归入适当的原材料组并称重。根据以下公式估算CF:活动数据(原材料重量)×相应原材料的排放因子(kg CO/kg)。
一次性包装和用户手册的总重量在0.062至1.013千克之间。塑料是最常见且排放最少的原材料(2.38 kg CO/kg)。MISD的估算隐含CF在0.07至3.3千克CO之间,其中9%至86%归因于NDAP。
本研究描述了一种简单且独立的计算方法,用于估算MISD的隐含CF。使用该方法,我们的结果显示,经尿道BPH手术中最新一次性MISD的估算CO排放量存在很大差异。因此,在未来MISD的开发中,缺乏CF信息应引起主要关注。